#METABOLOMICS WORKBENCH marian3101_20210622_142630 DATATRACK_ID:2715 STUDY_ID:ST001904 ANALYSIS_ID:AN003101 PROJECT_ID:PR001199
VERSION             	1
CREATED_ON             	August 16, 2021, 3:19 pm
#PROJECT
PR:PROJECT_TITLE                 	Lipidomic study
PR:PROJECT_TYPE                  	LC-MS analysis
PR:PROJECT_SUMMARY               	Lipidomic analysis of total membranes and outer membrane vesicles from the human
PR:PROJECT_SUMMARY               	gut comensal Bacteroides thetaiotaomicron. Strains used to perform the analysis:
PR:PROJECT_SUMMARY               	wild-tipe and mutants lacking the genes BT1522, BT1523, BT1524 and BT1526,
PR:PROJECT_SUMMARY               	involved in the synthesis of phosphoinosytol and Ceramide phosphinosytol
PR:INSTITUTE                     	Washington University, St. Louis
PR:DEPARTMENT                    	Molecular Microbiology
PR:LABORATORY                    	Feldman lab
PR:LAST_NAME                     	Sartorio
PR:FIRST_NAME                    	Mariana
PR:ADDRESS                       	660 S Euclid avenue, campus box 8230, 63110
PR:EMAIL                         	mgsartorio@wustl.edu
PR:PHONE                         	3147474477
PR:FUNDING_SOURCE                	NIH
PR:PUBLICATIONS                  	Lipidomics analysis of outer membrane vesicles and elucidation of the ceramide
PR:PUBLICATIONS                  	phosphoinositol biosynthetic pathway in Bacteroides thetaiotaomicron
PR:CONTRIBUTORS                  	Ezequiel Valguarnera, Mariana G. Sartorio, Fong-Fu Hsu and Mario F. Feldman
#STUDY
ST:STUDY_TITLE                   	Lipidomics analysis of outer membrane vesicles and elucidation of the ceramide
ST:STUDY_TITLE                   	phosphoinositol biosynthetic pathway in Bacteroides thetaiotaomicron
ST:STUDY_SUMMARY                 	In this work, we characterized the lipid composition of membranes and OMV from
ST:STUDY_SUMMARY                 	Bacteroides thetaiotaomicron VPI-5482. LC-MS analysis indicate that OMV carry
ST:STUDY_SUMMARY                 	sphingolipids, glycerophospholipids and serine-dipeptide lipids. Sphingolipid
ST:STUDY_SUMMARY                 	species represent more than 50% of the total lipid content of OMV. The most
ST:STUDY_SUMMARY                 	abundant sphingolipids in OMV are ceramide phosphoethanolamine (CerPE) and
ST:STUDY_SUMMARY                 	ceramide phosphoinositol (CerPI). Bioinformatic analysis allowed the
ST:STUDY_SUMMARY                 	identification of the BT1522-1526 operon putatively involved in CerPI synthesis.
ST:STUDY_SUMMARY                 	Mutagenesis studies revealed BT1522-1526 are essential for synthesis of PI and
ST:STUDY_SUMMARY                 	CerPI, confirming the role of this operon in biosynthesis of CerPI. BT1522-1526
ST:STUDY_SUMMARY                 	mutant strains lacking CerPI produced OMV that were indistinguishable from the
ST:STUDY_SUMMARY                 	wild-type strain, indicating that CerPI sphingolipid species are not involved in
ST:STUDY_SUMMARY                 	OMV biogenesis. Bacteroides sphingolipids are thought to modulate host-commensal
ST:STUDY_SUMMARY                 	interactions, and based on our data, we propose that OMV could act as long
ST:STUDY_SUMMARY                 	distance delivery vehicles for these molecules.
ST:INSTITUTE                     	Washington University, St. Louis
ST:DEPARTMENT                    	Molecular Microbiology
ST:LABORATORY                    	Feldman lab
ST:LAST_NAME                     	Sartorio
ST:FIRST_NAME                    	Mariana
ST:ADDRESS                       	660 S Euclid avenue, campus box 8230, 63110
ST:EMAIL                         	mgsartorio@wustl.edu
ST:STUDY_TYPE                    	Lipidic profile in wild-type and mutant strains
ST:PHONE                         	3147474477
#SUBJECT
SU:SUBJECT_TYPE                  	Bacteria
SU:SUBJECT_SPECIES               	Bacteroides thetaiotaomicron
SU:TAXONOMY_ID                   	818
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	OMV-WT-1	Genotype:wt	
SUBJECT_SAMPLE_FACTORS           	-	OMV-WT-2	Genotype:wt	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1522-1	Genotype:deltaBT1522	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1522-2	Genotype:deltaBT1522	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1523-1	Genotype:deltaBT1523	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1523-2	Genotype:deltaBT1523	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1524-1	Genotype:deltaBT1524	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1524-2	Genotype:deltaBT1524	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1526-1	Genotype:deltaBT1526	
SUBJECT_SAMPLE_FACTORS           	-	OMV-1526-2	Genotype:deltaBT1526	
SUBJECT_SAMPLE_FACTORS           	-	TM-WT-1	Genotype:wt	
SUBJECT_SAMPLE_FACTORS           	-	TM-WT-2	Genotype:wt	
SUBJECT_SAMPLE_FACTORS           	-	TM-1522-1	Genotype:deltaBT1522	
SUBJECT_SAMPLE_FACTORS           	-	TM-1522-2	Genotype:deltaBT1522	
SUBJECT_SAMPLE_FACTORS           	-	TM-1523-1	Genotype:deltaBT1523	
SUBJECT_SAMPLE_FACTORS           	-	TM-1523-2	Genotype:deltaBT1523	
SUBJECT_SAMPLE_FACTORS           	-	TM-1524-1	Genotype:deltaBT1524	
SUBJECT_SAMPLE_FACTORS           	-	TM-1524-2	Genotype:deltaBT1524	
SUBJECT_SAMPLE_FACTORS           	-	TM-1526-1	Genotype:deltaBT1526	
SUBJECT_SAMPLE_FACTORS           	-	TM-1526-2	Genotype:deltaBT1526	
#COLLECTION
CO:COLLECTION_SUMMARY            	B. thetaiotaomicron strains (wild-type and ΔBT1522-BT1526 mutants) were grown
CO:COLLECTION_SUMMARY            	overnight in an anaerobic chamber (Coy Laboratories) using an atmosphere of 10%
CO:COLLECTION_SUMMARY            	H2, 5% CO2, 85% N2. For liquid growth, Brain heart infusion (BHI) supplemented
CO:COLLECTION_SUMMARY            	with hemin and vitamin K3 was used. Cultures were then subjected to subcellular
CO:COLLECTION_SUMMARY            	fractionation to obtain total membranes and outer membrane vesicles (OMV)
CO:COLLECTION_SUMMARY            	preparation. OMV preparations: OMV were purified by ultracentrifugation of
CO:COLLECTION_SUMMARY            	filtered spent media from 150 ml of liquid culture as described previously (1).
CO:COLLECTION_SUMMARY            	OMV preparations were resuspended in PBS before lipid analyses. Protein content
CO:COLLECTION_SUMMARY            	was quantified using a DC protein assay kit (Bio-Rad). Fractions were aliquoted
CO:COLLECTION_SUMMARY            	and stored at -80°C until analyzed. Membrane preparations: Total membrane
CO:COLLECTION_SUMMARY            	preparations were performed by cell lysis and ultracentrifugation as previously
CO:COLLECTION_SUMMARY            	described (1). Total membranes from 150 ml of liquid culture were resuspended in
CO:COLLECTION_SUMMARY            	PBS using a 2-ml glass tissue grinder with a polytetrafluoroethylene (PTFE)
CO:COLLECTION_SUMMARY            	pestle (VWR). Protein content was quantified using a DC protein assay kit
CO:COLLECTION_SUMMARY            	(Bio-Rad). Fractions were stored aliquoted and stored at -80°C until analyzed.
CO:COLLECTION_SUMMARY            	References: 1. Elhenawy W, Debelyy MO, Feldman MF. Preferential packing of
CO:COLLECTION_SUMMARY            	acidic glycosidases and proteases into Bacteroides outer membrane vesicles.
CO:COLLECTION_SUMMARY            	mBio. 2014;5(2):e00909-14.
CO:SAMPLE_TYPE                   	Bacterial cells
#TREATMENT
TR:TREATMENT_SUMMARY             	No treatment displayed. Wild-type and mutant bacteria were grown in BHI
TR:TREATMENT_SUMMARY             	supplemented with vitamin K and Hemin
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Total lipids from OMV and TM were extracted based on the Bligh and Dyer
SP:SAMPLEPREP_SUMMARY            	chloroform:methanol method (1). Briefly, 2 volumes of methanol, 1 volume of
SP:SAMPLEPREP_SUMMARY            	chloroform, and 0.8 volumes of Milli-Q water were added to 1 volume of
SP:SAMPLEPREP_SUMMARY            	PBS-resuspended OMV or TM fractions into solvent-resistant glass tubes. Contents
SP:SAMPLEPREP_SUMMARY            	were mixed for 1 min by vortexing and 1 volume of chloroform was added to the
SP:SAMPLEPREP_SUMMARY            	mixture. Contents were mixed for another minute and tubes were centrifuged for 5
SP:SAMPLEPREP_SUMMARY            	min at 4000 rpm. After centrifugation, bottom phase (organic) was recovered
SP:SAMPLEPREP_SUMMARY            	using a glass Pasteur pipette and stored in solvent-sealed vials at -80°C until
SP:SAMPLEPREP_SUMMARY            	lipid analysis by LC-MS. References: 1. Bligh EG, Dyer WJ. A rapid method of
SP:SAMPLEPREP_SUMMARY            	total lipid extraction and purification. Can J Biochem Physiol.
SP:SAMPLEPREP_SUMMARY            	1959;37(8):911-7.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	LC/MS analyses were conducted on an Agilent 6550 A QTOF instrument with an
CH:CHROMATOGRAPHY_SUMMARY        	Agilent 1290 HPLC with autosampler, operated by Agilent Masshunter software
CH:CHROMATOGRAPHY_SUMMARY        	(Santa Clara, CA USA). Separation of the total lipid extracts was achieved by a
CH:CHROMATOGRAPHY_SUMMARY        	Thermo (Waltham MA, USA) 100 × 2.1 mm BETASIL 5 μm C18 column at a flow rate
CH:CHROMATOGRAPHY_SUMMARY        	of 300 μl/min at room temperature. The mobile phase contained 5 mM ammonium
CH:CHROMATOGRAPHY_SUMMARY        	formate (pH 5.0) both in solvent A, acetonitrile:water (60:40, v/v), and solvent
CH:CHROMATOGRAPHY_SUMMARY        	B, isopropanol:acetonitrile (90:10, v/v). A gradient elution in the following
CH:CHROMATOGRAPHY_SUMMARY        	manner was applied: 68% A, 0–1.5 min; 68–55% A, 1.5–4 min; 55–48% A,
CH:CHROMATOGRAPHY_SUMMARY        	4–5 min; 48–42% A, 5–8 min; 42–34% A, 8–11 min; 34–30% A, 11–14
CH:CHROMATOGRAPHY_SUMMARY        	min; 30–25% A, 14–18 min; 25–3% A, 18–23 min; 3–0% A, 25–30 min; 0%
CH:CHROMATOGRAPHY_SUMMARY        	A, 30–35 min; 68% A, 35–40 min. Both the positive-ion and negative-ion ESI
CH:CHROMATOGRAPHY_SUMMARY        	MS scans were acquired in the mass range of 200-2000 Da at a rate of 2
CH:CHROMATOGRAPHY_SUMMARY        	scans/min.
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 6550
CH:COLUMN_NAME                   	Thermo Betasil C18 (100 x 2.1mm, 5um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 6550 QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE/NEGATIVE
MS:MS_COMMENTS                   	ESI MS scans were acquired in the mass range of 200-2000 Da at a rate of 2 scans
MS:MS_COMMENTS                   	/min.
MS:MS_RESULTS_FILE               	ST001904_AN003101_Results.txt	UNITS:peak area	Has m/z:Yes	Has RT:No	RT units:No RT data
#END